Compare AbCellera Biologics Inc (ABCL) vs ProShares Ultra Bloomberg Natural Gas ETF (BOIL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? AbCellera Biologics Inc trades at $7.29 (market cap $2.35B), while ProShares Ultra Bloomberg Natural Gas ETF trades at $26.68. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | BOIL | |
|---|---|---|
Market Cap | $2.35B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $8.12 | $98.62 |
52-Week Low | $2.78 | $24.30 |
Enterprise Value | $1.99B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
BOIL trades at $26.65, up 0.79% today, but technical indicators signal a bearish trend with 14 sell signals versus 1 buy. The stock recently underwent a 1:2 split on May 28, 2026. Natural gas futures volatility, driven by weather forecasts and LNG demand, heavily influences price action. Key support sits at $25-26, with resistance at $27-28.
Outlook remains cautious due to technical weakness and reliance on volatile commodity prices. Investment opportunity exists for tactical traders betting on natural gas price swings, but risks include contango erosion and weather-dependent demand. Long-term value erosion is a significant concern given the ETF's structure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About ProShares Ultra Bloomberg Natural Gas ETF
BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →
